Generalized Myasthenia Gravis (gMG) is a condition where your muscles get weak and tired easily. This study is testing a new medicine called IMVT-1402 to see if it helps people with mild to severe gMG. The study will also check if the medicine is safe and if people can handle it well.

To join, you need to understand and agree to the rules, and you must have a certain level of gMG. You should not join if you've had a severe gMG episode recently or certain surgeries or cancers.

• Duration: The study involves multiple visits and assessments over time.
• Potential Benefits: You might receive a new treatment that could help with gMG symptoms.
• Risks: Like any study, there might be side effects or risks involved.

Note: Always discuss with your doctor to see if joining this study is right for you.